Editor's Pick

Bergner’s piece in The New York Times challenged the illusions of psychiatry. That made some people angry, outraged, or scared. The result is their comments section.

Risk of depression increased when children were taking methylphenidate for ADHD, but once they stopped taking the drug, depression risk dropped to normal levels.

God supported me during my psychosis. I was afraid that I would lose God when I took antipsychotics again. That had happened after my first forced medication.

A dialogue between Dr. Jim Phelps—a psychiatrist who questions whether MIA is doing more harm than good by reporting the results of long-term trials of psychiatric drugs—and Robert Whitaker, founder of MIA.

In his new book, former NIMH director Thomas Insel, while exploring the causes of poor mental health outcomes in the United States, omits any mention of NIMH studies that tell of how the drugs worsen long-term outcomes.

Stories of a state hospital leader who challenged the mental health system by placing patients as the most important people: Dr. Dean K. Brooks of Oregon State Hospital.

Reviews of four recent books reflecting various perspectives on the mental health system.

Hospitalized COVID patients over 65 were three times as likely to receive a dementia diagnosis if they took psychiatric drugs.

"You're not going to sell many drugs by saying your problem is your life experiences. It's far more effective to say your problem is in the brain. It's an imbalance, we can correct that imbalance, just take our product."

Sera Davidow is a filmmaker, activist, advocate, author, and mother of two very busy kids. As a survivor of physical, sexual, and emotional abuse...

Thomas Jobe was a collaborator in a longitudinal study that upended conventional thinking about antipsychotics. He died March 16.

Withholding antipsychotics may be beneficial for memory, the researchers write.

Ads pushing transcranial magnetic stimulation are everywhere. As someone harmed by the treatment, I believe they are misleading and unethical.

MIA’s Ayurdhi Dhar interviews Dana Becker about how therapeutic culture fails to adequately address women’s suffering.

Life in the DC was far too complicated for me to be able to just listen to my body and sleep on a thick yoga mat placed on the floor to alleviate my severe back pain.

We talk with Dr. Michael Hengartner about his new book which addresses the overprescribing of antidepressant drugs and critically examines the scientific evidence on their efficacy and safety.

Even after their own advisory committee criticized call tracing, leaders of the National Suicide Prevention Lifeline have been lobbying government for cutting-edge mass surveillance and tracking technology. Privacy experts are raising concerns.

I didn’t know that I had never fully experienced my emotional pain until I was thrown into an altered state. With “psychosis” I plowed through layers and layers of pain, alone in the night.

The child psychiatrist talks about the importance of seeing the big picture and why parents shouldn't "be afraid if their kid is in distress."

Micah Ingle interviews Sebastienne Grant about her work developing a critical psychology program to reimagine and restructure social systems.

I lost three years of my life to my first psychosis. I am living proof that your entire world can be smashed into a trillion pieces and you can recover and turn the broken pieces of glass into a kaleidoscope.

Do we take enough account of total drug exposure time when devising antidepressant tapering strategies?

A new research article asserts that the overuse of psychiatric drugs may create neurobiological changes that hamper long-term mental health recovery.

In JAMA Psychiatry, prominent psychiatrist Kenneth Kendler writes that psychiatric diagnoses are “working hypotheses, subject to change.”

Sean Gunderson, who was detained by the criminal justice system for 17 years after receiving an NGRI verdict, documents the life of a forensic psychiatry inmate.